Pfizer (PFE) Asset Utilization Ratio (2009 - 2026)

Pfizer (PFE) has reported Asset Utilization Ratio for 18 consecutive years, with 0.31 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Asset Utilization Ratio fell 26.33% year-over-year to 0.31 in Q2 2026; TTM through Jun 2026 was 0.31, a 26.33% decrease from a year earlier, with the FY2025 full-year figure at 0.3, up 0.99% from the prior year.
• Asset Utilization Ratio was 0.31 for Q2 2026 at Pfizer, up from 0.3 in the prior quarter.
• Over five years, Asset Utilization Ratio peaked at 0.6 in Q3 2022 and troughed at 0.2 in Q2 2024.
• A 5-year average of 0.37 and a median of 0.36 in 2024 frame the typical range for Asset Utilization Ratio.
• Across the five-year window, Asset Utilization Ratio slumped 50.16% in 2023 and soared 107.18% in 2025, its largest moves.
• Over 5 years, Asset Utilization Ratio stood at 0.5 in 2022, then sank by 43.86% to 0.28 in 2023, then advanced by 25.63% to 0.36 in 2024, then slipped by 15.63% to 0.3 in 2025, then increased by 3.78% to 0.31 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.31 (Q2 2026), 0.3 (Q1 2026), and 0.3 (Q4 2025), per Business Quant data.